Federal Register / Vol. 74, No. 94 / Monday, May 18, 2009 / Notices 23191 

Description: The Federal Office of 

Child Support Enforcement (OCSE) is 

implementing the Federal Parent 

Locator Service (FPLS) Child Support 

Services Portal (FCSSP) for users of the 

FPLS to access online web applications. 

The portal Registration Process will 

provide OCSE, States, employers and 

multistate financial institutions the 

ability to create a secure account to view 

data for their respective applications. In 

order for users to access the portal, 

registration is required. 

Respondents: OCSE, Employers, 

Multistate Financial Institutions and 

State Child Support Agencies. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden hours 

per response 

Total 

burden hours 

Registration Screens: Employers, Financial Institutions and State Child Support Agencies ............................................................................................... 520 1 0.10 52 

Estimated Total Annual Burden 

Hours: 52. 

In compliance with the requirements 

of Section 506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. E-mail address: 

infocollection@acf.hhs.gov. All requests 

should be identified by the title of the 

information collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Dated: May 13, 2009. 

Janean Chambers, 

Reports Clearance Officer. 

[FR Doc. E9–11495 Filed 5–15–09; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Center for Substance Abuse 

Prevention; Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given that the 

Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

Drug Testing Advisory Board (DTAB) 

will meet on June 2 and 3, 2009. 

The meeting is open to the public and 

will include discussion of the 

Mandatory Guidelines for Federal 

Workplace Drug Testing Programs, 

including implementation of the revised 

Mandatory Guidelines; Federal drug 

testing updates from the Department of 

Transportation, the Department of 

Defense, and the Nuclear Regulatory 

Commission; review of significant 

changes in the revised Mandatory 

Guidelines; and presentations on 

immunoassay kit issues, proficiency 

testing practice sets and rounds, 

instrumented initial test facilities, urine 

collector/collection site procedures, and 

Medical Review Officer training and 

certification. There will also be updates 

on a revised Federal custody and 

control form and expanded 

confirmatory drug test technologies. 

DTAB members and invited 

presenters will participate in this 

meeting through remote internet 

connection. On-site attendance by the 

public will be limited to space available. 

The meeting can also be accessed by the 

public via teleconference. To obtain 

teleconference call-in numbers and 

access codes, to make arrangements to 

attend on-site, or to request special 

accommodations for persons with 

disabilities, please communicate with 

DTAB’s Program Assistant, Ms. Giselle 

Hersh (see contact information below). 

SAMHSA would like to ensure that 

advisory committee meetings proceed in 

an orderly fashion, are conducted in a 

safe and secure environment, that the 

right of free speech is protected, and 

that the ability of SAMHSA Advisory 

Committees to accomplish their 

objectives is not disrupted. Therefore, 

the following procedures will be 

followed at all DTAB meetings: 

• Attendees are subject to security 

screening, including identification 

(driver’s license) review, metal detector 

screening, and inspection of briefcases, 

packages, etc. Each attendee will be 

issued a security badge that must be 

worn at all times while in the building. 

• Any interested person who wishes 

to be assured of the right to make an oral 

presentation during the Public 

Comment portion of the DTAB meeting 

must register with Ms. Hersh before the 

meeting. 

• Those who have not registered 

before the meeting will only be invited 

to speak at the discretion of the Chair 

and should submit their request to the 

Designated Federal Official on the day 

of the meeting. 

• Public Comment participants who 

are designated to speak may be 

questioned only by the Chair or DTAB 

members. 

• Audience members may not present 

comments or questions to DTAB 

members unless recognized by the 

Chair. 

• Attendees at the meeting are asked 

to maintain order and not display 

behavior that is disruptive to the 

meeting (i.e., shouting from the 

audience, loud outbursts). 

• We ask that attendees not approach 

the DTAB table area during the meeting 

without permission from the Chair or 

the Designated Federal Official. 

• The DTAB Chair or Designated 

Federal Official will note on the record 

any disruptive behavior and will ask the 

person to cease the behavior or else 

leave the meeting room. 

Substantive program information, a 

summary of the meeting, and a roster of 

DTAB members may be obtained as 


cprice-sewell on PRODPC61 with NOTICES
23192 Federal Register / Vol. 74, No. 94 / Monday, May 18, 2009 / Notices 

soon as possible after the meeting, either 

by accessing the SAMHSA Committee 

Web site, https://www.nac.samhsa.gov/ 

DTAB/meetings.aspx, or by contacting 

Ms. Hersh. The transcript for the 

meeting will also be available on the 

SAMHSA Committee Web site within 

three weeks after the meeting. 

Committee Name: Substance Abuse and 

Mental Health Services Administration Drug 

Testing Advisory Board. 

Date/Time/Type: June 2, 2009 from 10 a.m. 

to 4:30 p.m. EDT: OPEN. June 3, 2009 from 

10 a.m. to 1 p.m. EDT: OPEN. 

Place: Sugarloaf and Seneca Conference 

Rooms, 1 Choke Cherry Road, Rockville, 

Maryland 20857. 

Contact: Ms. Giselle Hersh, Program 

Assistant, SAMHSA Drug Testing Advisory 

Board, 1 Choke Cherry Road, Room 2–1042, 

Rockville, Maryland 20857, Telephone: 240– 

276–2600, Fax: 240–276–2610, E-mail: 

Giselle.Hersh@samhsa.hhs.gov. 

Toian Vaughn, 

Committee Management Officer, Substance 

Abuse and Mental Health, Services 

Administration. 

[FR Doc. E9–11427 Filed 5–15–09; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group; Neurological Sciences and 

Disorders C. 

Date: June 8–9, 2009 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: William C. Benzing, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, Division Of Extramural 

Research, NINDS/NIH/DHHS/Neuroscience 

Center, 6001 Executive Boulevard, Suite 

3208, MSC 9529, Bethesda, MD 20892, (301) 

496–0660, benzingw@mail.nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group; Neurological Sciences and 

Disorders A. 

Date: June 24, 2009 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz Carlton Hotel, 1150 22nd Street, 

NW., Washington, DC 20037. 

Contact Person: Richard D. Crosland, PhD, 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research, 

NINDS/NIH/DHHS, Neuroscience Center, 

6001 Executive Blvd., Suite 3208, MSC 9529, 

Bethesda, MD 20892–9529, 301–496–9223. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group; Neurological Sciences and 

Disorders B. 

Date: June 25–26, 2009. 

Time: 7 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: State Plaza Hotel, 2117 E Street, 

NW., Washington, DC 20037. 

Contact Person: Ernest W Lyons, PhD, 

Scientific Review Officer, Scientific Review 

Branch, NINDS/NIH/DHHS, Neuroscience 

Center, 6001 Executive Blvd., Suite 3208, 

MSC 9529, Bethesda, MD 20892–9529, 301– 

496–4056. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: May 12, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–11583 Filed 5–15–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Review R13. 

Date: June 17, 2009. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call) 

Contact Person: Mary Kelly, Scientific 

Review Officer, Scientific Review Branch, 

National Inst. of Dental & Craniofacial 

Research, NIH 6701 Democracy Blvd., room 

672, MSC 4878, Bethesda, MD 20892–4878, 

301–594–4809, mary_kelly@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: May 11, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–11486 Filed 5–15–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel—NIBIB Training 

2009/10. 

Date: June 26, 2009. 

Time: 11 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy Blvd., 

242, Bethesda, MD 20892. (Virtual Meeting) 

Contact Person: Ruixia Zhou, Ph.D., 

Scientific Review Officer, 6707 Democracy 

Boulevard, Suite 957, Bethesda, MD 20892. 

301–496–4773. zhour@mail.nih.gov. 


cprice-sewell on PRODPC61 with NOTICES